Novartis Investigative Site

Voula, GR 166 73

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Cardiovascular Disease and Lipoprotein(a), Heart Failure With Reduced Ejection Fraction (HF-rEF)

Studies at this site

• Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
• Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF) — NO_LONGER_AVAILABLE
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed